First, the key update for Week 52 is that seasonal influenza activity in the United States is increasing, with varying levels of activity across different regions. 

In terms of viruses, the majority of detected viruses are Influenza A(H3N2). 

Genetic characterization data are now being reported, which help monitor evolutionary changes in influenza viruses. 

Outpatient respiratory illness visits are increasing, with 4.8% of patient visits reported through the ILINet system being due to respiratory illness. 

The ILI activity map shows that 10 jurisdictions experienced moderate activity, while 31 jurisdictions experienced high or very high activity. 

Long-term care facilities have reported 1.3% of facilities having at least one influenza-positive test among residents. 

Hospitalizations due to influenza are increasing, with a cumulative hospitalization rate of 2.6 per 100,000 population in the FluSurv-NET system. 

19.9% of deaths during Week 52 were attributed to pneumonia, influenza, or COVID-19, above the epidemic threshold. 

No influenza-associated pediatric deaths were reported during Week 52. 

Overall, the data suggest that influenza activity is on the rise, with increasing outpatient visits, hospitalizations, and mortality. Vaccination and antiviral treatment are recommended to prevent and manage influenza.